Roth MKM initiated coverage of Aspen Aerogels with a Buy rating and $22 price target. The firm believes that 2024 “represents a key inflection point,” with Aspen poised to demonstrate positive adjusted EBITDA for the year and significant growth for its thermal barrier products. The firm anticipates outperformance as profitability continues to ramp with better asset utilization, the analyst tells investors.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ASPN:
- Aspen Aerogels management to meet with Seaport Research
- Aspen Aerogels price target raised to $24 from $23 at Seaport Research
- Aspen Aerogels price target raised to $18 from $17 at Canaccord
- Aspen Aerogels price target raised to $21 from $17 at Craig-Hallum
- Aspen Aerogels price target raised to $20 from $17 at TD Cowen
